Relentless innovation from the leaders in glucose health
Dexcom has set the standard in glucose biosensing for 25 years and counting. Our best-in-class technologies empower people to know what is happening in their bodies in real time, helping them to better understand the many factors that impact their glucose and overall health.
Smart devices sold separately.‡
Dexcom G7 and Dexcom G7 15 Day—the world's most powerful CGM systems1
Dexcom G7 CGM Systems deliver proven results2-6 with best-in-class accuracy1 and a growing ecosystem of connected partners that help ease the burden of living with diabetes. They’re designed for all types of diabetes, sending glucose numbers to your phone‡ or receiver in real time, giving you the knowledge to better control diabetes for healthier tomorrows.7,8
Stelo Glucose Biosensor
The power to personalize your diet and exercise choices starts with Stelo. It sends personal glucose insights right to your phone,‡ giving you all the information you need to make healthier habits become second nature.
No prescription. No fingersticks, ever. Just results.
Empowering people to take control of health
Since 1999, Dexcom has been developing innovative technology that has transformed how people manage diabetes and track their glucose. We think of ourselves as partners in their journey, empowering them to live confidently and take control of their health with our life-changing products.
Get Started with Dexcom
Take the first step towards better health! Glucose health is a critical part of overall health, and Dexcom has the best sensing solution for you or your loved one regardless of your health goals. We'll make getting started easy from the comfort of your home.
*A study was conducted to assess the sensor life where 73.9% of sensors lasted the full 15 days. When using the product per the package labeling, approximately 26% of sensors may not last for the full 15 days. †Excludes implantable CGM systems. ‡For Dexcom G7 compatible devices, visit dexcom.com/compatibility. For Stelo app compatibility information, visit stelo.com/compatibility.
1 Dexcom, Data on file, 2025. 2 Beck RW, et al. JAMA. 2017;317(4):371-378. 3 Beck RW, et al. Ann Intern Med. 2017;167(6):365-374. 4 Martens T, et al. JAMA. 2021;325(22):2262-2272. 5 Garg SK, et al. Diabetes Technol Ther. 2025;27(6):413-502. 6 Welsh JB, et al. J Diabetes Sci Technol. 2024;18(1):143-7. 7 Ehrhardt N, et al. Clin Diabetes. 2020:38(2):126-131. 8 Clark TL, et al. Diabetes Technol Ther. 2024;26(10):700-8.
BRIEF SAFETY STATEMENT: Failure to use the Dexcom Continuous Glucose Monitoring System and its components according to the instructions for use provided with your device and available at https://www.dexcom.com/safety-information and to properly consider all indications, contraindications, warnings, precautions, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence and/or making a treatment decision that may result in injury. If your glucose alerts and readings from the Dexcom CGM do not match symptoms, use a blood glucose meter to make diabetes treatment decisions. Seek medical advice and attention when appropriate, including for any medical emergency.
STELO IMPORTANT INFORMATION: Consult your healthcare provider before making any medication adjustments based on your sensor readings and do not take any other medical action based on your sensor readings without consulting your healthcare provider. Do not use if you have problematic hypoglycemia. Failure to use Stelo and its components according to the instructions for use provided and to properly consider all indications, contraindications, warnings, and cautions in those instructions for use may result in you missing a severe hypoglycemia (low blood glucose) or hyperglycemia (high blood glucose) occurrence. If your sensor readings are not consistent with your symptoms, a blood glucose meter may be an option as needed and consult your healthcare provider. Seek medical advice and attention when appropriate, including before making any medication adjustments and/or for any medical emergency.
INDICATIONS FOR USE: The Stelo Glucose Biosensor System is an over-the-counter (OTC) integrated Continuous Glucose Monitor (iCGM) intended to continuously measure, record, analyze, and display glucose values in people 18 years and older not on insulin. The Stelo Glucose Biosensor System helps to detect normal (euglycemic) and low or high (dysglycemic) glucose levels. The Stelo Glucose Biosensor System may also help the user better understand how lifestyle and behavior modification, including diet and exercise, impact glucose excursion. The user is not intended to take medical action based on the device output without consultation with a qualified healthcare professional.
MAT-4823